Back to search

Article

Stabilized dengue virus 2 envelope subunit vaccine redirects the neutralizing antibody response to all E-domains

2024-07-18

Abstract excerpt

The four-dengue virus (DENV) serotypes cause several hundred million infections annually. Several live-attenuated tetravalent dengue vaccines (LAVs) are at different stages of clinical testing and regulatory approval. A major hurdle faced by the two leading LAVs is uneven replication of vaccine serotypes stimulating a dominant response to one serotype at the expense of the other three, leading to the potential for...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
34b64a3e-436d-5e8f-b941-e2f6ee7446d4
DOI
10.1101/2024.07.18.604114
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Stabilized dengue virus 2 envelope subunit vaccine redirects the neutralizing antibody response to all E-domainsDOI 10.1101/2024.07.18.604114
Select a neighboring publication to make it the new centre.